... Sato Y, Fujiwara T, Mine T, Shomura H, Homma S, Maeda Y, Tokunaga N,Ikeda Y, Ishihara Y, Yamada A, Tanaka N, Itoh K, Harada M, Todo S:Immunological evaluation of personalized peptide vaccination ... vaccination augments anti -cancer immunity in a mouse modelof gastric cancer. Journal of TranslationalMedicine 2011 9:140.Submit your next manuscript to BioMed Central and take full advantage ... cell vaccination augments anti -cancer immunity in a mouse modelof gastric cancer Natasja K van den Engel1*†, Dominik Rüttinger1†, Margareta Rusan1, Robert Kammerer2, Wolfgang Zimmermann3,Rudolf...
... Camilla Mollatt, and Anne.K. Hjelmerud of Norwegian Radium Hospital, and Åsmund Larsen and EllenM. Brevik of Algeta ASA, for technical assistance. We thank Lars Abrahamsen and Thomas Ramdahl ... primary and meta-static breastcancer [3].Tumor cell-targeted alpha emitters have the potentialto improve therapy of hematological malignancies and micrometastatic disease. Alpha particles have ... studies and carried outinterpretation and analysis of data including dosimetry calculation and writing of manuscript. JB performed radiolabeling and contributed inmanuscript writing. JN and NA carried...
... molecular processes underlying breast cancer metastasis.Mechanisms contributing to breast cancer metastasis A critical step towards the generation of mouse models of breastcancer is the understanding ... [12]MMTV-Neu;SR2F Mammary gland 86.8 8 a 12 Lung [70]MMTV-NeuYB;TβRI(AAD) Mammary gland 8.9 a 65 Lung 2 [67]MMTV-NeuYD;TβRI(AAD) Mammary gland 4.4 a 44 >ExtravascularMMTV-NeuYB;TβRII(∆Cyt) Mammary gland ... nodes and in the lungs [45]. Tumor formation and progression in these mice is characterized by four stages:hyperplasia, adenoma/mammary intra-epithelial neoplasia, and early and late carcinoma [46]....
... Nelson DF, Croghan IT, Achenbach SJ, Crow-son CS, Hartmann LC, O'Fallon WM: Risk ofbreastcancerand breast cancer characteristics in women treated with supra-diaphragmatic radiation for Hodgkin ... RTto all lymph nodes areas that are included in a standardmantle field (neck, supraclavicular, infraclavicular, axilla and mediastinum). Two patients had RT to modifiedmantle field where axillary ... Pathological characteristics ofbreast cancers as wellas tumor location within the breast were recorded. Weevaluated the pathological type, T-stage, and axillarynodal status of the first tumor in patients...
... Africa. A random-ized trial in Uganda [59] comparing home-based and facility-based care also found similar rates of viral loadsuppression, failure and mortality. A community-basedprogram offering ... Jinja Trial Team: Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet ... Munger A, Kabwinja A, Mpunga J, Chazel E, Jeannin A, Szumilin E, Kamoto K, Harries A: Nurses and medical assistants taking charge: task-shifting HIV care and HAART initiation in resource-constrained...
... University of Delaware, Newark, DE, USA and 2Department of Mechanical and Aeronautical Engineering, Civil and Environmental Engineering, and Land, Air, and Water Resources, University of California, ... length. A was found to varyin a parabolic manner and was modeled as A( θ) = a( 40 - θ)2 + b(40 - θ) + A 40,(11)where A 40 is the value ofA at 40° of knee flexion, and a and b are constants ... nonlinear and time varying, accurate control of muscles to producefunctional movements is very difficult. Accurate and predictive mathematical models can facilitatethe design of stimulation patterns...
... facility and maintained in accordance with institutional gui delinesapproved by the University of Maryland, Baltimore AnimalCare and Use Committee. To compare RIA and CNT-FETassays, Brca1f/f; ... signaling pathway as a selective target of familial breastcancer therapy. Curr Mol Med 2008,8:727-740.26. Vadgama JV, Wu Y, Datta G, Khan H, Chillar R: Plasma insulin-like growthfactor-I and serum ... IGF-binding protein 3 can be associated with theprogression ofbreast cancer, and predict the risk ofrecurrenceand theprobability of survival in African-American and Hispanic women.Oncology...
... SURGERY 8MANAGEMENT OFBREASTCANCER IN WOMEN2+ A All women with early stage invasive breastcancer who are candidates for breast conserving surgery should be offered the choice ofbreast conserving ... with ductal carcinoma in situ who are candidates for breast surgery should be offered the choice of lumpectomy or mastectomy. Management ofbreastcancer in women A national clinical guideline1 ... 16 28MANAGEMENT OFBREASTCANCER IN WOMEN A Women with breastcancer should be offered audiotapes or follow up summary letters of important consultations. A Clinical encounters with...
... extra words, and transpositions), and each led to an associated alteration of the grammar. PST accounted for children's omission of content words and the gradual increase in utterance ... English paraphrases of the actual PRISM productions. All variables are italicized; these may match against any symbol, but all occurrences ofa variable -" ~'. ~,~atch to the same element. ... of Learning and Motivation, Volume 13, 1979. Berwick, R. Computational analogues of constraints on grammars: Amodelof syntactic acquisition. Proceedings of the 18th Annual Conference of the...
... Learning About BreastCancer Breast cancer is a malignant (muh-LIG-nent) tumor that starts withcells in the breast. Malignant means that the cells are cancerous and may spread to other ... cells are abnormal or cancerous, a biopsy may tell ifthey are still in one place or if they have started to spread.Non-invasive breastcancer A non-invasive breastcancer is a growth of abnormal ... chance that DCISmight become invasive cancer later on. Invasive breast cancer With invasive breast cancer, the abnormal cells have spread beyondthe place where they started. Invasive breast cancer...
... art breast radiotherapy as an adjunct to mod-ern breast conserving surgery.ConclusionsEarly stage breastcancer can be treated with breast con-servin g therapy and accelerated partial breast ... by a shortenedradiation treatme nt time (86%) and delivery of radiationto a smaller area of the body (77%). Twelve of thepatients (27%) indicated that having alocal treatment facility was a ... Strauss JB, Shah AP, Rao RD, Bernard DA, Griem KL: Radiationrecall reaction with Docetaxel administration after accelerated partial breast irradiation with electronic brachytherapy. Brachytherapy...
... serum of Apcs-/-, wt.DNase I. Apcs-/- and ash.DNase I. Apcs-/- mice. Values are expressed in arbitrary ELISA units (AEU) related to a standard positive sample that was assigned a value of 100 AEU. ... anti-ssDNA antibodies in mice before and 7 days and 14 days post-injection of LPS. Values are expressed in arbitrary ELISA units (AEU) related to a standard positive sample that was assigned a value ... therapeutic use of a recombinant actin-resistant, salt-resistant and hyperactiveDNase I has potential to alter the developmentof autoimmu-nity.Materials and methodsConstruction of DNase transgenic...
... late-effect, all patients being fol-lowed up after a median of 4 years after their breast cancer diagnosis. The primary aim was to calculate eachpatient’ s absolute volume of the gland receiving a defined ... thetarget volume included the breast (after BCS) or thechest wall (after MRM), the ipsilateral supra -and infra-clavicular foss a, ipsilateral lymph nodes along the inter-nal mammary arte ry and ... 3 3Radiotherapy, surgical and chemotherapy treatment characteristics for cases(group A) and controls (group B).1Age: Age at follow-up2Obstime: observation time from breastcancer diagno...